I. Castellví

4.7k total citations
78 papers, 833 citations indexed

About

I. Castellví is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, I. Castellví has authored 78 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 28 papers in Pulmonary and Respiratory Medicine and 28 papers in Rheumatology. Recurrent topics in I. Castellví's work include Systemic Sclerosis and Related Diseases (28 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers) and Inflammatory Myopathies and Dermatomyositis (13 papers). I. Castellví is often cited by papers focused on Systemic Sclerosis and Related Diseases (28 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers) and Inflammatory Myopathies and Dermatomyositis (13 papers). I. Castellví collaborates with scholars based in Spain, United States and Italy. I. Castellví's co-authors include Hèctor Corominas, Javier Narváez, Cèsar Díaz‐Torné, Patricia Moya, Iago Pinal‐Fernandez, María Molina‐Molina, Albert Selva-O’Callaghan, Peré Domingo, Jordi Casademont and Joan M. Nolla and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

I. Castellví

68 papers receiving 826 citations

Peers

I. Castellví
I. Castellví
Citations per year, relative to I. Castellví I. Castellví (= 1×) peers Taio Naniwa

Countries citing papers authored by I. Castellví

Since Specialization
Citations

This map shows the geographic impact of I. Castellví's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Castellví with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Castellví more than expected).

Fields of papers citing papers by I. Castellví

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Castellví. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Castellví. The network helps show where I. Castellví may publish in the future.

Co-authorship network of co-authors of I. Castellví

This figure shows the co-authorship network connecting the top 25 collaborators of I. Castellví. A scholar is included among the top collaborators of I. Castellví based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Castellví. I. Castellví is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alonso, Ana, Ana Giménez‐Capitán, Laura López, et al.. (2024). Older Patients With Interstitial Lung Disease Feature a Distinct Clinical Profile. SHILAP Revista de lepidopterología. 6(4). 100374–100374. 1 indexed citations
2.
Santos, C. Sieiro, Diego Castillo, Patrícia Rivera, et al.. (2024). Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies–related interstitial lung disease. Lara D. Veeken. 64(SI). SI88–SI96. 1 indexed citations
3.
López-Gómez, Marta, Patricia Moya, Hye Sang Park, et al.. (2024). Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice. Diagnostics. 14(22). 2583–2583. 3 indexed citations
4.
Park, Hye Sang, Patricia Moya, Esther Moga, et al.. (2024). Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies. Journal of Clinical Medicine. 13(20). 6069–6069. 2 indexed citations
5.
Castellví, I., Ma Àngels Ortiz, Douglas E. Brough, et al.. (2023). Impaired Regulation by IL-35 in Systemic Sclerosis. International Journal of Molecular Sciences. 24(13). 10567–10567. 4 indexed citations
6.
Santos, C. Sieiro, Elisa Llurba, Montserrat Díaz, et al.. (2023). AB0630 PREGNANCY IN AUTOIMMUNE DISEASES: THE IMPACT OF PREGNANCY PLANNING ON REPRODUCTIVE OUTCOMES IN A MULTIDISCIPLINARY PRECONCEPTION OUTPATIENT CLINIC. Annals of the Rheumatic Diseases. 82. 1517–1518. 1 indexed citations
7.
Güler, Aslıhan Avanoğlu, et al.. (2023). Systemic sclerosis and interstitial lung disease: From pathogenesis, to screening, diagnosis, and classification. Revista Colombiana de Reumatología. 31. S54–S66.
8.
Hoffmann‐Vold, Anna‐Maria, Chiara Pellicano, A. Romaniello, et al.. (2023). The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. Autoimmunity Reviews. 22(4). 103290–103290. 19 indexed citations
9.
Castellví, I., Diego Castillo, Hèctor Corominas, et al.. (2022). Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 9. 973918–973918. 7 indexed citations
10.
Peñacoba, Patricia, Diego Castillo, Esther Ortiz Martínez, et al.. (2021). Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 11(11). 1998–1998. 17 indexed citations
11.
Zamora, Carlos, Tarek Carlos Salman-Monte, Ma Àngels Ortiz, et al.. (2021). Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE. International Journal of Molecular Sciences. 22(9). 4719–4719. 6 indexed citations
12.
Moya, Patricia, et al.. (2021). "The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica". PLoS ONE. 16(9). e0255131–e0255131. 7 indexed citations
13.
Martínez, María Ángeles, Ernesto Trallero‐Araguás, Laura Martínez‐Martínez, et al.. (2021). Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice. Frontiers in Immunology. 11. 625896–625896. 4 indexed citations
14.
Narváez, Javier, Tarek Carlos Salman-Monte, Raúl Castellanos‐Moreira, et al.. (2020). A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. Lupus. 29(10). 1216–1226. 11 indexed citations
15.
Dorca, Jordi, et al.. (2020). Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data. Rheumatology International. 40(5). 719–726. 25 indexed citations
16.
Suárez‐Calvet, Xavier, Jorge Alonso‐Pérez, I. Castellví, et al.. (2020). Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(3). 15 indexed citations
17.
Romero-Bueno, Fredeswinda, Ernesto Trallero‐Araguás, Juan Carlos Ruiz‐Rodríguez, et al.. (2020). Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Seminars in Arthritis and Rheumatism. 50(4). 776–790. 127 indexed citations
18.
Borrell, Helena, Javier Narváez, Juan José Alegre Sancho, et al.. (2016). Shrinking lung syndrome in systemic lupus erythematosus. Medicine. 95(33). e4626–e4626. 44 indexed citations
19.
Corominas, Hèctor, Vera Ortiz-Santamaría, I. Castellví, et al.. (2015). Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatology International. 36(3). 365–369. 14 indexed citations
20.
Castellví, I., et al.. (2010). Successful treatment of SAPHO syndrome with adalimumab: a case report. Clinical Rheumatology. 29(10). 1205–1207. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026